ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,044Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 2456

$1.39M Total Retail Price of All Prescriptions

Rank: 15 out of 2456

510 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 21,121 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

49 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,669 1,567 1 9
FUROSEMIDE 1,104 981 2 8
SIMVASTATIN 882 812 3 2
LISINOPRIL 834 716 4 1
LEVOTHYROXINE SODIUM 680 581 5 4
TRAZODONE HCL 607 522 6 17
METOPROLOL TARTRATE 558 500 7 10
OMEPRAZOLE 540 382 8 3
CITALOPRAM HBR 538 474 9 14
GABAPENTIN 519 391 10 16
POTASSIUM CHLORIDE 474 456 11 33
AMLODIPINE BESYLATE 460 382 12 5
METFORMIN HCL 452 380 13 11
DONEPEZIL HCL 374 362 14 23
MIRTAZAPINE 344 317 15 29
OLANZAPINE 330 272 16 57
QUETIAPINE FUMARATE 329 292 17 47
ATENOLOL 314 275 18 6
RISPERIDONE 290 236 19 50
GLIPIZIDE 280 246 20 46
HYDRALAZINE HCL 275 227 21 105
DIVALPROEX SODIUM 271 205 22 51
SERTRALINE HCL 262 152 23 21
LANTUS 253 195 24 44
NOVOLOG 253 188 24 100
NAMENDA 230 230 26 42
PREDNISONE 223 206 27 39
HYDROCHLOROTHIAZIDE 218 211 28 7
FLUOXETINE HCL 203 150 29 45
METOPROLOL SUCCINATE 195 149 30 13
HYDROCODONE-ACETAMINOPHEN 188 182 S3 31 20
DIGOXIN 167 161 32 49
TAMSULOSIN HCL 160 146 33 32
CYMBALTA 157 134 34 65
RANITIDINE HCL 152 127 35 31
METOLAZONE 150 139 36 271
SPIRIVA 149 129 37 43
PANTOPRAZOLE SODIUM 148 130 38 37
CLOZAPINE 148 55 38 75
SEROQUEL 148 133 38 102
ALLOPURINOL 142 130 41 27
TRAMADOL HCL 135 112 42 24
LEVETIRACETAM 134 113 43 90
CLOPIDOGREL 132 114 44 55
LACTULOSE 127 98 45 88
VENLAFAXINE HCL ER 126 106 46 92
ABILIFY 126 63 46 95
CARBIDOPA-LEVODOPA 124 113 48 82
NYSTATIN-TRIAMCINOLONE 121 120 49 283
CARVEDILOL 116 110 50 54
JANUVIA 116 87 50 81
ALBUTEROL SULFATE 115 101 52 165
RAMIPRIL 114 114 53 158
ATORVASTATIN CALCIUM 113 99 54 12
POLYETHYLENE GLYCOL 3350 111 65 55 64
FINASTERIDE 109 109 56 66
NYSTATIN 107 94 57 99
FLUDROCORTISONE ACETATE 106 105 58 260
ALENDRONATE SODIUM 104 101 59 19
LIDODERM 103 103 60 58
PRAVASTATIN SODIUM 101 86 61 15
PAROXETINE HCL 100 83 62 56
GENERLAC 100 60 62 142
LEVOFLOXACIN 90 79 64 103
PLAVIX 89 74 65 79
GLUCAGEN 88 35 66 318
IPRATROPIUM-ALBUTEROL 85 53 67 85
ADVAIR DISKUS 84 62 68 36
LABETALOL HCL 83 71 69 128
LATANOPROST 82 78 70 156
LEVEMIR 81 46 71 174
NIASPAN 77 70 72 181
KLOR-CON M20 76 51 73 69
OXYCODONE-ACETAMINOPHEN 76 64 S2 73 35
FLUTICASONE PROPIONATE 74 60 75 30
LAMOTRIGINE 74 47 75 120
DIVALPROEX SODIUM ER 69 38 77 178
ZOLPIDEM TARTRATE 68 63 78 28
FENTANYL 66 66 S2 79 115
TRIAMCINOLONE ACETONIDE 66 61 79 131
DILTIAZEM 24HR CD 65 62 81 113
RENVELA 62 28 82 282
SANTYL 62 58 82 323
LOSARTAN POTASSIUM 61 60 84 18
ISOSORBIDE MONONITRATE ER 61 54 84 48
SPIRONOLACTONE 60 41 86 73
GLIPIZIDE ER 60 44 86 89
AGGRENOX 58 58 88 246
CEFTRIAXONE 55 45 89 236
HUMALOG 52 33 90 123
CALCITRIOL 52 48 90 153
OXYBUTYNIN CHLORIDE 51 39 92 152
CIPROFLOXACIN HCL 51 45 92 87
NYSTOP 50 43 94 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.